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We prepared in vitro an mRNA transcript coding for the erythroagglutinating subunit of the kidney bean glycoprotein 
phytohemagglutinin, E-PHA. The mRNA, injected into Xenopus oocytes, synthesized E-PHA carrying two Asn-linked 
carbohydrate chains, one of which was processed and acquired resistance to endo-D-N-acetylglucosaminidase H, as occurs 
in the native bean cells. When the mannose analog I-deoxymannojirimycin, an inhibitor of mammalian Golgi mannosi- 
dase I, was included in the oocyte culture medium, the acquisition of endo-/I-N-acetylglucosaminidase H resistance was 
abolished, indicating that also in an amphibian cell the inhibitor blocks a key reaction in Golgi-mediated processing. 
I-Deoxymannojirimycin; Oocyte; Glycoprotein processing; Phytohemagglutinin; Golgi complex; (Xenopus laevis) 
1. INTRODUCTION 
Golgi-mannosidase I is the first enzyme acting 
on the Asn-linked carbohydrate chains of glyco- 
proteins which pass through the Golgi apparatus in 
mammalian cells. The enzyme removes the 
cul,2-linked mannoses from the oligomannose 
chains producing the MansGlcNacz structure, a 
key intermediate for further processing leading to 
the complex N-linked chains [l]. The mannose 
analog 1-deoxymannojirimycin (dMM) inhibits 
mammalian mannosidase I in vivo and therefore 
blocks the Golgi-mediated processing of Asn- 
linked chains [2-51. There appears, however, to be 
no evidence that such a block can also be obtained 
in non-mammalian cells. Xenopus oocytes are 
capable of carrying on several steps of processing 
and transport of foreign proteins synthesized upon 
mRNA injection [6,7]. We have recently studied 
expression of the kidney bean lectin phytohemag- 
glutinin (PHA), a well-characterized glycoprotein 
[8], in Xenopus oocytes, and have also shown that 
the conversion of high oligomannose to complex 
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carbohydrate chains can take place in these cells 
[9]. Both in its native cellular environment and in 
oocytes injected with bean RNA, PHA is syn- 
thesized on the endoplasmic reticulum; cotransla- 
tionally a signal peptide is removed and two 
Asn-linked chains are added. During passage 
through the Golgi complex, the carbohydrate 
chain distal to the N-terminus is extensively 
modified and acquires endo-fl-N-acetylglucos- 
aminidase H (endo H) resistance [9, lo]. Consider- 
ing the widespread use of Xenopus oocytes in 
studying the molecular cell biology of proteins, we 
decided to attempt he gaining of more insights in- 
to the regulation of carbohydrate chain modifica- 
tion in these cells by examining the effect of dMM 
on the processing of PHA. 
2. MATERIALS AND METHODS 
The strategy to obtain polyadenylated mRNA for a PHA 
polypeptide was as follows. The entire pPVL134 cDNA se- 
quence [II], coding for a lectin-like protein, was excised from 
the pBR322 vector and inserted into the PstI site of the Blue- 
script M13-, KS polylinker, vector (Stratagene, San Diego, 
CA); the fragment was oriented downstream of the T7 pro- 
moter and the resulting recombinant plasmid was termed 
pB7LLP. The coding sequence for the lectin-like protein was 
excised from pB7LPP by Sac1 and X&I digestion and sub- 
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stituted with a 622 bp fragment containing the coding sequence 
for E-PHA, isolated from the genomic clone pdlecl 1121 by 
NsiI and XbaI digestion. The resulting plasmid was termed 
pB7lecl. Note that the XbaI site covers the codon for the 
COOH-terminal leucine both in the lectin-like protein and in 
the E-PHA sequence and therefore the end of the E-PHA se- 
quence was perfectly reconstructed, in this case followed by the 
3’-uncoding region of the lectin-like protein cDNA clone, in- 
cluding a poly(A)tail. Also, at the 5 ‘-end, the 622 bp genomic 
fragment contained only a TAC trinucleotide preceding the 
ATG protein initiation sequence of E-PHA. 
The method for in vitro transcription of the construct, to 
yield mRNA which can function in the oocytes, was a modifica- 
tion of the procedure of Krieg and Melton [13]. The 25 ~1 in 
vitro transcription mixture consisted of 1 @g pB7lecl linearized 
with EcoRI, 400 pM rUTP, rCTP and rATP, 40 pM rGTP, 
4OOpM 7mGpppG, 2.5 pg BSA, 60 U RNAsin’ (Promega 
Biotec, Madison, WI), 30 mM DTT, 8 mM MgCl2, 50 mM 
NaCl, 40 mM Tris-Cl (pH 8.0). 10 U T7 RNA polymerase were 
then added and the mixture incubated at 37°C. After 30 min the 
rGTP concentration was adjusted to 400pM and again 10 U 
polymerase added. After an additional 30 min at 37”C, the mix- 
ture was brought to 100~1 with water and adjusted to 10 mM 
EDTA and 700 mM ammonium acetate; 20 pg yeast tRNA was 
then added and the solution (final volume 133 pl) extracted with 
phenol-chloroform before precipitation of nucleic acids which 
was performed by adding 2.5 vols ethanol. After centrifugation 
and two washings with 80% ethanol, the pellet was resuspended 
in 25 ,zI water and stored at - 80°C. This was the solution used 
for in vitro translation (2~1) and oocyte injection 
(40 nl/oocyte). 
Bean (P. vulgaris cv. Greensleeves) RNA was prepared from 
endoplasmic reticulum-bound polysomes isolated from 
developing cotyledons, as in [14]. In vitro translation was car- 
ried out using the reticulocyte lysate (Amersham, Bucks, 
England) supplemented with 462.5 kBq L-[4,5-‘Hlleucine 
(5.62 TBq/mmol, Amersham) per 25 ~1 reaction mixture. 
Oocyte preparation, injection, labelling with [‘Hlleucine, and 
homogenization were performed as described [9] but injected 
oocytes were incubated in Barth medium overnight before 24 h 
labelling followed by a chase consisting in 6 h medium plus 18 h 
in medium supplemented with 10 mM unlabelled leucine. In 
some experiments, oocytes were injected with tunicamycin 
(40 fig/ml) and then preincubated for 3 h in Barth medium sup- 
plemented with 2.5 pg/ml tunicamycin before pulse-chase 
labelling in the presence of the same concentration of the in- 
hibitor. Treatment with dMM was carried out by preincubating 
oocytes in medium supplemented with 5 mM dMM for 3 h 
before pulse-chase labelling, which was done in the presence of 
the same concentration of dMM. Immunoprecipitation using 
anti-PHA monospecific antibodies, treatment of immuno- 
precipitated PHA with endo+-N-acetylglucosaminidase H 
(from Strepfomyces griseus; Miles Lab., Elkhart, IN), SDS- 
PAGE and fluorography were performed as in [9]. 
3. RESULTS AND DISCUSSION 
Since our purpose was to investigate functions 
performed by oocyte enzymes, it was necessary to 
avoid the coinjection of undefined bean mRNAs 
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together with PHA mRNA. We therefore con- 
structed a plasmid, termed pB7lec1, for the in vitro 
production of a polyadenylated mRNA containing 
the whole sequence coding for E-PHA, including a 
21 -amino-acid putative signal peptide. The 
pB7lecl transcript, translated in vitro, directed the 
synthesis of a polypeptide indistinguishable in size 
from E-PHA produced by a bean RNA prepara- 
tion (fig.1, cf. lanes 1,2). 
Xenopus oocytes were injected with the pB7lecl 
transcript or with bean RNA. Oocytes were then 
labelled with [3H]leucine for 24 h followed by a 
24 h chase to allow all processing events to occur, 
and PHA was immunoprecipitated from the cell 
homogenates. PHA synthesized by bean RNA 
gave a broad band (fig.2, lane l), due to micro- 
heterogeneity of the processed carbohydrate chains 
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Fig. 1. SDS-PAGE and fluorography of E-PHA synthesized in 
vitro and comparison with E-PHA synthesized in oocytes 
treated with Tm. Reticulocyte lysate was supplemented with: 
bean RNA (lane l), pB7lecl transcript (lanes 2,4), no RNA 
(lane 3); total translation products were loaded on the gel. Lane 
5: E-PHA isolated from oocytes treated with Tm and injected 
with pB7lecl transcript; unglycosylated (arrowhead), singly* 
and doubly** glycosylated polypeptides are indicated. Positions 
of molecular mass markers are given on the right. 
Volume 234, number 2 FEBS LETTERS 
endn H: - + - + - + 
Tm: - - - + + - ---- - -+ 
dMM: - - + - - - ----++- 
July 1988 
Fig.2. SDS-PAGE and fluorography showing the effect of dMM on the processing of E-PHA. PHA was isolated by immunoprecipita- 
tion from oocyte homogenates (lanes 1-14) or a preparation of bean endoplasmic reticulum, which contains PHA in its precursor with 
only oligomannose carbohydrate chains (lane 15). For endo H digestion, PHA was incubated under the appropriate conditions [lo] 
in the presence of endo H (lanes 8,10,12) or in the absence of the enzyme, as a control (lanes 7,9,11). 
of both the E-PHA and L-PHA subunits [9]. The 
pB7lecl transcript was efficiently translated in the 
oocytes (fig.2, lane 2); in this case too the product 
gave a broad band. These immunoprecipitable 
proteins were not synthesized in uninjected control 
oocytes (fig.2, lane 6). Since cloned E-PHA had 
not been expressed in vivo before, we performed 
experiments to investigate its processing. In the 
presence of the N-glycosylation inhibitor tunica- 
mycin (Tm) the oocytes synthesized unglycosylated 
E-PHA having electrophoretic mobility slightly 
higher than that of E-PHA synthesized in vitro 
(fig.1, cf. lanes 4,5; note that inhibition of 
glycosylation by Tm was not complete in the ex- 
periment in lane 5: this allows the detection of 
singly and doubly glycosylated E-PHA polypep- 
tides as well), and identical to that of E-PHA syn- 
thesized in Tm-treated oocytes injected with bean 
RNA, which is known to undergo correct removal 
of the signal peptide [9] (fig.2, cf. lanes 4,5; the up- 
per and lower bands in lane 5 represent un- 
glycosylated E-PHA and L-PHA, respectively): 
these results indicate that the 21-amino-acid se- 
quence at the N-terminus of the cloned E-PHA 
functions as a removable signal peptide. Endo H 
cleaves oligomannose chains between the two 
proximal N-acetylglucosamine residues but is 
unable to cleave complex chains. When E-PHA 
synthesized by the pB7lecl transcript was digested 
with endo H, most of the material increased in 
mobility corresponding to removal of one of the 
two carbohydrate chains (fig.2, lanes 9,10), as oc- 
curs in the cae of PHA synthesized in oocytes in- 
jected with bean RNA (fig.2, lanes 7,8, and see 
also [9]). 
The above results indicated that E-PHA was 
correctly processed; the effect of dMM on the pro- 
cessing of E-PHA synthesized in oocytes injected 
with the pB7lecl transcript was therefore in- 
vestigated. The inhibitor did not affect the survival 
of the oocytes and the amount of immuno- 
precipitable PHA accumulated. E-PHA synthe- 
sized in the presence of dMM migrated on 
SDS-PAGE as a sharp band (fig.2, lane 3), sug- 
gesting that its carbohydrate chains were less 
heterogeneous than those present when the oocytes 
were not treated with the inhibitor. Endo H diges- 
tion (fig.2, lanes 11,12) revealed that in fact dMM 
fully blocked the formation of complex side 
chains: both chains could be removed by the en- 
zyme and the product migrated just above un- 
glycosylated E-PHA made in the oocytes in the 
presence of tunicamycin, as expected for a 
polypeptide still carrying one inner N-acetylglucos- 
amine per glycan attachment site (fig.2, cf. lanes 
12,13). 
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E-PHA made in dMM-treated oocytes was com- 
pared with PHA isolated from an endoplasmic 
reticulum-enriched fraction of developing bean 
cotyledons pulse labelled with [3H]leucine: this 
precursor PHA has not yet reached the Golgi com- 
plex and therefore has both side chains still in the 
oligomannose form [IO]. E-PHA made in dMM- 
treated oocytes migrated slightly below the E-PHA 
precursor present in the endoplasmic reticulum of 
bean cells (fig.2, cf. lanes 14,15; upper and lower 
bands in lane 15 represent E-PHA and L-PHA 
precursor, respectively): probably, removal of one 
or a few mannoses also occurred in the oocytes in 
the presence of dMM. Mammalian cells contain 
mannosidases insensitive to dMM [1,16]: some of 
these appear to be endoplasmic reticulum- 
associated enzymes and can process high mannose 
chains down to Man&lcNac2, a structure which is 
not a substrate for the action of the Golgi glycosyl- 
transferases and mannosidase II which build up 
the endo H resistant complex chains. Our results 
would suggest that similar enzymes are also present 
in the oocytes. Alternatively, some mannose 
residues could have been removed from E-PHA in 
a compartment subsequent to the Golgi complex: 
PHA, unlike other plant storage proteins which 
are secreted by oocytes [17], is accumulated inside 
the cells, in an as yet unidentified compartment 
191. 
The present results indicate that dMM inhibits 
the conversion of oligomannose to complex oligo- 
saccharides in Xenopus oocytes. This suggests that 
also in an amphibian cell the action of a man- 
nosidase is a prerequisite for the following Golgi- 
associated processing events. 
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